MR Angiography with Gadofosveset Trisodium for Peripheral Vascular Disease: Phase II Trial

Radiology

Volumn 229, Issue 3, 2003, Pages 811-820

  Perreault, Pierre ^a   Edelman, Mark A ^b   Baum, Richard A ^c   Yucel, E Kent ^c   Weisskoff, Robert M ^d   Shamsi, Kohkan ^e   Mohler III, Emile R ^f  

^a UNIVERSITY OF MONTREAL   (Canada)

^b RUSH NORTH SHORE MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d EPIX Pharmaceuticals   (United States)

^e BAYER PHARMA AG   (Germany)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Angiography, contrast media; Arteries, extremities; Magnetic resonance (MR), vascular studies

Indexed keywords

GADOFOSVESET; PLACEBO; SODIUM DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYTIC METHOD; ANGIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; BIOSAFETY; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOUBLE BLIND PROCEDURE; EVALUATION; FEMALE; HEADACHE; HUMAN; HYPOCALCEMIA; HYPOTHESIS; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INJECTION; INTERMETHOD COMPARISON; LERICHE SYNDROME; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PARESTHESIA; PERIPHERAL VASCULAR DISEASE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STANDARD; TASTE DISORDER; X RAY ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PERIPHERAL VASCULAR DISEASES; ROC CURVE; SAFETY;

EID: 0344584515     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2293021180     Document Type: Article

References (16)

1. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286:1317-1324.
2. Baum RA, Rutter CM, Sunshine JH, et al. Multicenter trial to evaluate vascular magnetic resonance angiography of the lower extremity: American College of Radiology Rapid Technology Assessment Group. JAMA 1995; 274:875-880.
3. Quinn SF, Sheley RC, Semonsen KG, Leonardo VJ, Kojima K, Szumowski J. Aortic and lower-extremity arterial disease: evaluation with MR angiography versus conventional angiography. Radiology 1998; 206:693-701.
4. Grist TM, Korosec FR, Peters DC, et al. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 1998; 207:539-544.
5. Grist TM. MRA of the abdominal aorta and lower extremities. J Magn Reson Imaging 2000; 11:32-43.
6. Frayne R, Grist TM, Swan JS, Peters DC, Korosec FR, Mistretta CA. 3D MR DSA: effects of injection protocol and image masking. J Magn Reson Imaging 2000; 12:476-487.
7. Frayne R, Grist TM, Korosec FR, et al. MR angiography with three-dimensional MR digital subtraction angiography. Top Magn Reson Imaging 1996; 8:366-388.
8. Hany TF, Carroll TJ, Omary RA, et al. Aorta and runoff vessels: single-injection MR angiography with automated table movement compared with multiinjection time-resolved MR angiography-initial results. Radiology 2001; 221:266-272.
9. Omary RA, Henseler KP, Unal O, et al. Comparison of intraarterial and IV gadolinium-enhanced MR angiography with digital subtraction angiography for the detection of renal artery stenosis in pigs. AJR Am J Roentgenol 2002; 178:119-123.
10. Willinek WA, Gieseke J, Conrad R, et al. Randomly segmented central k-space ordering in high-spatial-resolution contrast-enhanced MR angiography of the supraaortic arteries: initial experience. Radiology 2002; 225:583-588.
11. Rofsky NM, Adelman MA. MR angiography in the evaluation of atherosclerotic peripheral vascular disease. Radiology 2000; 214: 325-338.
12. Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998; 207:529-538.
13. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-845.
14. Snidow JJ, Harris VJ, Trerotola SO, et al. Interpretations and treatment decisions based on MR angiography versus conventional arteriography in symptomatic lower extremity ischemia. J Vasc Interv Radiol 1995; 6:595-603.
15. Poon E, Yucel EK, Pagan-Marin H, Kayne H. Iliac artery stenosis measurements: comparison of two-dimensional time-of-flight and three-dimensional dynamic gadolinium-enhanced MR angiography. AJR Am J Roentgenol 1997; 169:1139-1144.
16. Yucel EK, Kaufman JA, Geller SC, Waltman AC. Atherosclerotic occlusive disease of the lower extremity: prospective evaluation with two-dimensional time-of-flight MR angiography. Radiology 1993; 187:637-641.